PCC0105003
PCC0105003 is a potent MARK inhibitor. PCC0105003 can be used in the study of neuropathic pain[1].
Product Specifications
UNSPSC
12352005
Target
MARK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/pcc0105003.html
Purity
99.88
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
FC(F)(C1=CN=C(N=C1NCC2=NNC=C2)NC3=CC=C(C=C3)N4CCOCC4)F
Molecular Formula
C19H20F3N7O
Molecular Weight
419.40
References & Citations
[1]Shi YQ, et al. A novel role for microtubule affinity-regulating kinases in neuropathic pain. Br J Pharmacol. 2024 Jul;181 (13) :2012-2032.|[2]Shi YQ, et al. A novel role for microtubule affinity-regulating kinases in neuropathic pain. Br J Pharmacol. 2024 Jul;181 (13) :2012-2032.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
